View Drug - Isosulfan Blue
Jump to: Basic Info Purpose Indications Warnings Reactions

Isosulfan Blue

Generic: ISOSULFAN BLUE

100%
Basic Information
Manufacturer
Meitheal Pharmaceuticals Inc.
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
SUBCUTANEOUS
FDA Set ID
d36ae5af-6351-497a-9151-82bcb2c62fa0
Indications & Usage
1 INDICATIONS AND USAGE Isosulfan Blue Injection 1% upon subcutaneous administration, delineates the lymphatic vessels draining the region of injection.

It is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; lymph node response to therapeutic modalities ( 1.1 ).

1.1 Lymphatic Vessel Delineation Isosulfan Blue Injection 1% upon subcutaneous administration, delineates lymphatic vessels draining the region of injection.

It is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities.
Adverse Reactions
6 ADVERSE REACTIONS Hypersensitivity Reactions : Hypersensitivity reactions occurring approximately 2% of patients and include life-threatening anaphylactic reactions with respiratory distress, shock, angioedema, urticaria, pruritus.

A death has been reported following IV administration of a similar compound ( 6 ).

To report SUSPECTED ADVERSE REACTIONS, contact Meitheal Pharmaceuticals Inc.

at 1-844-824-8426 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .

6.1 Postmarketing Experience Hypersensitivity Reactions: Case series report an overall incidence of hypersensitivity reactions in approximately 2% of patients.

Life-threatening anaphylactic reactions have occurred.

Manifestations include respiratory distress, shock, angioedema, urticaria, pruritus.

A death has been reported following administration of a similar compound employed to estimate the depth of a severe burn.

Reactions are more likely to occur in patients with a personal or family history of bronchial asthma, significant allergies, drug reactions or previous reactions to triphenylmethane dyes [see Warnings and Precautions ( 5 )] .

Laboratory tests: Isosulfan blue 1% interferes with measurements of oxygen saturation by pulse oximetry and of methemoglobin by gas analyzer [see Warnings and Precautions ( 5 )] .

Skin: Transient or long-term (tattooing) blue coloration.